Black patients with early-stage lung cancer were less likely to receive curative treatment than White patients, despite all having Medicare coverage, study finds. Dr. Olivia Lynch, a postdoctoral ...

A diagnosis of ductal carcinoma in situ, or DCIS, often comes as a surprise during a routine mammogram. While the news is understandably taxing, it is important to remember that DCIS is a noninvasive, ...

To better predict these risks, the new guidelines recommend that all stage 2 and 3 colorectal tumors undergo molecular ...

Faith that God was going to use me and my health would improve and motivate me to keep me pushing on my journey and not look ...

Researchers reported at the 2026 European Lung Cancer Congress that Hernexeos (zongertinib) led to high response rates and disease control in patients with advanced HER2-mutant non–small cell lung ...

Drs. Nunnery and McCann discuss the evolving HER2-positive breast cancer treatment paradigm in the latest episode of “Breast Cancer Briefing.” ...

Dr. Brittany Dulmage discusses how management of immune-related side effects can help patients stay on immunotherapy without compromising its effectiveness. As immunotherapy continues to transform ...

Global efforts in prevention, early detection and collaboration are improving cancer care access, but disparities persist based on where patients live. At the National Comprehensive Cancer Network ...

Their conversation centered around the evolving HER2-positive breast cancer treatment paradigm. The experts highlighted that although this disease was once associated with a poor prognosis, targeted ...

Nunnery and McCann discuss the evolving HER2-positive breast cancer treatment paradigm in the latest episode of “Breast Cancer Briefing.” ...

Coverage from NCCN 2026 highlights global care delivery, younger patient needs, survivorship strategies and safer immunotherapy management. At the 2026 Annual Conference of the National Comprehensive ...

KRAS G12D-targeted protein degrader setidegrasib showed antitumor activity with tolerable safety profile in patients with ...